Distinct Single-cell Immune Ecosystems Distinguish True and De Novo HBV-related Hepatocellular Carcinoma Recurrences

六氯环己烷 肝细胞癌 免疫系统 细胞毒性T细胞 免疫监视 生物 免疫疗法 CD8型 癌症研究 肿瘤微环境 免疫学 遗传学 体外
作者
Shu‐Ling Chen,Cheng Huang,Guanrui Liao,Hui–Chuan Sun,Yubin Xie,Jianping Wang,Minghui He,Huanjing Hu,Zhengde Dai,Xiaoxue Ren,Xuezhen Zeng,Qianwen Zeng,Guopei Zhang,Changyi Liao,Wenlin Xie,Shunli Shen,Shaoqiang Li,Sui Peng,Dong-Ming Kuang,Qiang Zhao,Dan G. Duda,Ming Kuang
标识
DOI:10.1101/2022.06.02.494526
摘要

Summary Revealing differential tumor immune microenvironment (TIME) characteristics between true versus de novo hepatocellular carcinoma (HCC) recurrence could help optimal development and use of immunotherapies. Here, we studied the TIME of recurrent HBV-related HCCs by 5’and VDJ single-cell and bulk RNA-sequencing, flow cytometry, and multiplexed immunofluorescence. Analyses of mutational profiles, evolutionary trajectories, and clonal architecture using whole-exome sequencing identified de novo versus true recurrences, some of which occurred before clinical diagnosis. The TIME of truly recurrent HCCs was characterized by an increased abundance in KLRB1 + CD8 + T cells with memory phenotype and low cytotoxicity. In contrast, we found an enrichment in cytotoxic and exhausted CD8 + T cells in the TIME of de novo recurrent HCCs. Transcriptomic and interaction analyses showed an upregulated GDF15 expression level on HCC cells in proximity to dendritic cells, which may have dampened antigen presentation and inhibited anti-tumor immunity in the TIME of truly recurrent lesions. In contrast, we found that myeloid cells’ crosstalk with T cells mediated T cell exhaustion and immunosuppression in the TIME of de novo recurrent HCC. In conclusion, our results support genomic diagnosis and immune profiling for guiding immunotherapy implementation based on the type of HCC recurrence and TIME. Highlights Truly recurrent lesions are seeded before primary tumor diagnosis, and that de novo cancer can occur earlier than the clinically used 2-year limit. ScRNA-seq unravels distinct immune ecosystems in true versus de novo HCC recurrences, highlighting the need for different immunotherapy strategies for two types of HCC recurrence. CD8 + T cells in de novo recurrence displayed cytotoxic and exhausted phenotypes while those in truly recurrent lesions showed a memory phenotype with weak cytotoxicity. HCC cells expressing the inhibitory molecule GDF15 were in the proximity of DCs only in truly recurrent lesions. High GDF15 expression level was associated with truly recurrent HCC and worse prognosis. Graphical abstract
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
建议保存本图,每天支付宝扫一扫(相册选取)领红包
实时播报
熊孩子完成签到 ,获得积分10
1秒前
djdh完成签到 ,获得积分10
2秒前
haimianbaobao完成签到,获得积分10
2秒前
老鼠咕噜应助粗心的忆山采纳,获得10
4秒前
6秒前
7秒前
搜集达人应助科研通管家采纳,获得10
7秒前
慕青应助科研通管家采纳,获得10
7秒前
7秒前
cctv18应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得30
7秒前
思源应助科研通管家采纳,获得30
7秒前
7秒前
7秒前
7秒前
打打应助冷静的雨泽采纳,获得10
10秒前
12秒前
Hannah完成签到,获得积分10
13秒前
13秒前
14秒前
15秒前
霍师傅发布了新的文献求助10
16秒前
KK发布了新的文献求助10
16秒前
巨型肥猫发布了新的文献求助10
18秒前
Hello应助霍师傅采纳,获得10
20秒前
21秒前
22秒前
李爱国应助明明采纳,获得10
23秒前
23秒前
24秒前
吴宵发布了新的文献求助10
25秒前
Zhuzhu发布了新的文献求助10
25秒前
ybma完成签到 ,获得积分10
26秒前
方一发布了新的文献求助10
29秒前
尘土silence完成签到,获得积分10
30秒前
渡星河发布了新的社区帖子
31秒前
万能图书馆应助巨型肥猫采纳,获得10
31秒前
研友_VZG7GZ应助快乐每一天采纳,获得10
32秒前
科研通AI2S应助Rainbow7采纳,获得10
34秒前
SciGPT应助Hannah采纳,获得10
38秒前
高分求助中
Teaching Social and Emotional Learning in Physical Education 1000
Multifunctionality Agriculture: A New Paradigm for European Agriculture and Rural Development 500
grouting procedures for ground source heat pump 500
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Second 版本 500
超快激光原理与技术 魏志义 310
The Chemistry of Carbonyl Compounds and Derivatives 300
中国志愿服务发展报告(2022~2023) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2338203
求助须知:如何正确求助?哪些是违规求助? 2028182
关于积分的说明 5075259
捐赠科研通 1775458
什么是DOI,文献DOI怎么找? 888135
版权声明 556008
科研通“疑难数据库(出版商)”最低求助积分说明 473511